Neximmune Inc (NASDAQ: NEXI) shares are trading lower by 4.78% to $2.79 Monday morning. The stock is declining on downward momentum due to the company's Board of Directors on Thursday unanimously approving a plan to dissolve the company, pending stockholder approval. Additionally, they are considering ways to maximize the company's ...

Full story available on Benzinga.com